glp 1 compounding news Out of Shortage, Into Controversy: The Fight Over GLP-1 Republican Administration Maintains Exclusivity Stance

A review article published in 2022 in Frontiers in Endocrinology posits that drugs that target GLP-1 to treat type 2 diabetes (T2D) could potentially treat Alzheimers as well

Review the need for prescribing a GLP-1 RA agent and stop treatment if no longer required due to not achieving desired clinical effect as per NICE CG28

PlexusDx providers distinguish between medication-related and situational anxiety to guide treatment adjustments

Many patients have reported dry mouth, enamel erosion, inflamed gums, and even cracked or loose teeth

Both of these medications work well for type II diabetics and pre-diabetic patients at controlling insulin resistance

BBR has proven to promote insulin secretion, enhance insulin sensitivity, inhibit gluconeogenesis, reduce fat accumulation, avert steatosis and fibrosis, display anti-inflammatory and antioxidant properties, and modulate the immune system in both animal and human studies [5]